Plain-English translation of NCT00590239 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing new endoscopic imaging methods to detect early cancer in patients with Barrett's esophagus—a condition where chronic acid reflux damages the lining of your esophagus. Currently, doctors use standard biopsies (tissue samples) to check for cancer, but these can miss small areas of concern. The study aims to see if advanced imaging techniques can spot dangerous changes earlier and more reliably.
Barrett's esophagus significantly increases your risk of developing esophageal cancer, but the current method of checking for cancer involves taking many random tissue samples, which can be time-consuming and may still miss early signs. This trial exists to find better, more accurate ways to detect cancer at an early stage when it's most treatable.
You likely qualify if…
You likely don't qualify if…
You would come in for an endoscopy procedure (a small camera is passed down your throat while you're sedated) where doctors will use new imaging techniques alongside or instead of standard biopsies to look for early signs of cancer. The visit will be similar to a regular Barrett's esophagus screening, but with the addition of these new detection methods being tested. Your doctors will explain exactly what to expect and answer any questions before you begin.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States